A Phase II Trial of Nifurtimox for Refractory or Relapsed Neuroblastoma and Relapsed Medulloblastoma
Clinical Trial Information
Trial Contact: El-Shami, Jessica; Francois, Laetitia Claire; Leffin, Melissa; Spinelli, Jennifer
The purpose of this study is to determine whether nifurtimox in combination with chemotherapy are effective in the treatment of neuroblastoma and medulloblastoma.
Ages Eligible for Study: up to 21 Years; Genders Eligible for Study: Both; Accepts Healthy Volunteers: No